Effects of glycation with chitooligosaccharide on digestion and fermentation processes of lactoferrin in vitro

Copyright © 2023. Published by Elsevier B.V..

This study aimed to investigate the digestion and fermentation processes of lactoferrin (LF) glycated with chitooligosaccharide (COS) under a controlled Maillard reaction, utilizing the in vitro digestion and fermentation model, and to compare the results of these processes to LF undertaken without glycation. After gastrointestinal digestion, the products of the LF-COS conjugate were found to have more fragments with lower molecular weight than LF, and the antioxidant capabilities (via ABTS and ORAC assay) of the LF-COS conjugate digesta also increased. In addition, the undigested fractions could be further fermented by the intestinal microbiota. Compared with LF, more short-chain fatty acids (SCFAs) were generated (from 2397.40 to 2623.10 μg/g), and more species of microbiota (from 451.78 to 568.10) were observed in LF-COS conjugate treatment. Furthermore, the relative abundance of Bacteroides and Faecalibacterium that could utilize carbohydrates and metabolic intermediates to produce SCFAs also increased in LF-COS conjugate than that of LF. Our results demonstrated that glycation with COS under the controlled wet-heat treatment Maillard reaction could modify the digestion of LF and have a potentially positive influence on the intestinal microbiota community.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:234

Enthalten in:

International journal of biological macromolecules - 234(2023) vom: 15. Apr., Seite 123762

Sprache:

Englisch

Beteiligte Personen:

Wang, Wenduo [VerfasserIn]
Chen, Chun [VerfasserIn]
Zhou, Chunxia [VerfasserIn]
Tang, Zhongsheng [VerfasserIn]
Luo, Donghui [VerfasserIn]
Fu, Xiong [VerfasserIn]
Zhu, Siming [VerfasserIn]
Yang, Xinhe [VerfasserIn]

Links:

Volltext

Themen:

Chitooligosaccharide
Digestion
EC 3.4.21.-
Fermentation
Glycation
Journal Article
Lactoferrin
Oligochitosan

Anmerkungen:

Date Completed 23.03.2023

Date Revised 23.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijbiomac.2023.123762

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35319235X